Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Cardiovascular Research Center, National Cheng Kung University, Tainan, Taiwan.
Department of Pharmacology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Atherosclerosis. 2020 Mar;297:16-24. doi: 10.1016/j.atherosclerosis.2020.01.029. Epub 2020 Feb 6.
Inflammation, oxidative stress, matrix degradation, medial calcification and vascular smooth muscle cell (VSMC) loss are prominent features in abdominal aortic aneurysm (AAA). VSMC phenotypic switch to a proinflammatory state and VSMC apoptosis could be targetable mechanisms implicated in the pathogenesis of AAA formation. Herein, we investigated the hypothesis that a xanthine derivative (KMUP-3) might suppress AAA through inhibition of VSMC phenotypic switch and apoptosis.
In vitro, VSMC calcification was induced using β-glycerophosphate. In vivo, AAA was induced using angiotensin II (1000 ng/kg per minute) infusion for 4 weeks in apolipoprotein E-deficient mice.
As determined by alizarin red S staining and calcium content measurements, KMUP-3 suppressed VSMC calcification. During VSMC calcification, KMUP-3 inhibited mTOR and β-catenin upregulation, essential for VSMC phenotypic switch, while it enhanced AMP-activated protein kinase (AMPK) activation that protects against VSMC phenotypic switch. Moreover, KMUP-3 attenuated VSMC apoptosis with an increased Bcl-2/Bax ratio and reduced activated caspase-3 expression. During AAA formation, treatment with KMUP-3 inhibited phosphorylated mTOR expression and increased phosphorylated AMPK expression in the medial layer. In addition, KMUP-3 treatment suppressed aortic dilatation together with reduction in proinflammatory cytokines and infiltrating macrophages, attenuation of medial VSMC apoptosis and mitigation of reactive oxygen species generation, matrix-degrading proteinase activities, elastin breakdown and vascular calcification.
Treatment with KMUP-3 inhibits aneurysm growth possibly through its interference with signaling pathways involved in VSMC phenotypic switch and apoptosis. These findings provide a proof-of-concept validation for VSMC dysfunction as a potential therapeutic target in AAA.
炎症、氧化应激、基质降解、中层钙化和血管平滑肌细胞(VSMC)丢失是腹主动脉瘤(AAA)的突出特征。VSMC 表型向促炎状态的转变和 VSMC 凋亡可能是 AAA 形成发病机制中的潜在靶点机制。在此,我们研究了一个假设,即黄嘌呤衍生物(KMUP-3)可能通过抑制 VSMC 表型转变和凋亡来抑制 AAA。
在体外,使用β-甘油磷酸诱导 VSMC 钙化。在体内,使用血管紧张素 II(1000ng/kg/min)输注 4 周在载脂蛋白 E 缺陷小鼠中诱导 AAA。
通过茜素红 S 染色和钙含量测定,KMUP-3 抑制了 VSMC 钙化。在 VSMC 钙化过程中,KMUP-3 抑制了 mTOR 和β-连环蛋白的上调,这对 VSMC 表型转变至关重要,而增强了 AMP 激活蛋白激酶(AMPK)的激活,可防止 VSMC 表型转变。此外,KMUP-3 通过增加 Bcl-2/Bax 比值和减少活化的 caspase-3 表达来减轻 VSMC 凋亡。在 AAA 形成过程中,KMUP-3 处理抑制了中层磷酸化 mTOR 的表达和磷酸化 AMPK 的表达。此外,KMUP-3 治疗抑制了主动脉扩张,同时减少了促炎细胞因子和浸润的巨噬细胞,减轻了中层 VSMC 凋亡,减轻了活性氧生成、基质降解蛋白酶活性、弹性蛋白分解和血管钙化。
KMUP-3 的治疗可能通过干扰参与 VSMC 表型转变和凋亡的信号通路来抑制动脉瘤生长。这些发现为 VSMC 功能障碍作为 AAA 的潜在治疗靶点提供了概念验证。